Description

Brief Prescribing information:
Composition: 5m1 syrup contains 2.5 mg levocetirizine dihydrochloride. Pharmaco-therapeutic Group:
Anti allergic Agent, 3rd generation Non-sedating Anti-histamine. Therapeutic Indications: Levocetirizine
is indicated for symptomatic treatment of allergic rhinitis (including persistent allergic rhinitis), chronic
idiopathic urticaria and allergic conjunctivitis. Posology and Method of administration: Adults and
adolescent 12 years and above: The daily recommended dose is 5mg (2 teaspoonful or 10m1 syrup).
Elderly: Adjustment of the dose is recommended in elderly patients with compromised renal functions.
Children aged 6 year to under 12 years: The daily recommended dose is 2.5mg (1 teaspoonful or 5m1
syrup). Children aged 6 months to under 6 years: The daily recommended dose is 1.25mg (1/2 teaspoon
or 2.5m1 syrup). Duration of use: The duration of use depends on the type, duration and course of
complaints, For Hay fever 3-6 weeks and in case of short-term pollen exposure as little as one week,
is generally sufficient. Clinical experience with 5 mg levocetirizine is currently available for a 6 month
treatment period. For chronic urticaria and chronic allergic rhinitis, up to one year’s clinical experience
is available for the racemate, and up to 18 months in patient with pruritus associated with atopic dermatitis.
Contra-indications: History of hypersensitivity to levocetirizine or any of the other constituents of the
formulation or to any piperazine derivatives. Patients with severe renal impairment at less than 10 ml/min
creatinine clearance. Warning and precautions for use: Precaution is recommended with intake of
alcohol. Patients with rare hereditary problems of galactose intolerance, the Lapp – lactase deficiency
or glucose-galactose malabsorption should not take this medicine.